Nektar Therapeutics Sustainability Reports

Nektar Therapeutics is a clinical-stage biotechnology company focused on the development of novel immunology therapies. The company utilizes its proprietary technology platforms to discover and develop treatments for autoimmune and inflammatory diseases.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

LEI: 5299005I24806IOIYE03

FIGI: BBG001S7RDK1

12 reports from 2007 to 2025

• Nektar Therapeutics 2025 Annual Report on Form 10-K
• Nektar Therapeutics 2024 Annual Report on Form 10-K
• Nektar Therapeutics 2023 Annual Report on Form 10-K
• Nektar Therapeutics 2020 Annual Report on Form 10-K
• Nektar Therapeutics 2017 Annual Report on Form 10-K